Cardiac Marker Analyzer Product Analysis, Business & Marketing Strategy of Cardiac Marker Companies - 2nd Edition

1.    Executive Summary

2.    Cardiac Marker Companies – Comparative Tests Analysis

3.    Cardiac Marker Analyzer – Competitive Product Analysis

4.    Alere
4.1    Alere Triage
4.1.1    Triage MeterPro Analyzer

4.2    Alere Cardiology Net Sales & Forecast (2011 - 2022) 

5.    Response Biomedical
5.1    Cardiovascular Testing
5.1.1    Acute Myocardial Infarction (Heart Attack) Testing
5.1.2    Congestive Heart Failure (“CHF”) Testing
5.1.3    Thrombotic Disease Testing

5.2    RAMP Platform
5.2.1    RAMP 200
5.2.2    RAMP Reader

5.3    Response Biomedical Cardiovascular Net Sales (2011 – 2022) 

6.    Abbott Point of Care
6.1    The i–STAT System

6.2    Abbott Laboratories Point of Care Diagnostics Sales (2011 – 2022) 

7.    Roche
7.1    Cobas h 232 POC System

8.    Siemens Healthineers
8.1    Stratus CS Analyzer

8.2    Siemens Healthineers establishes global Digital Ecosystem to drive Digitalization of Healthcare

9.    Beckman Coulter
9.1    Access 2 Immunoassay System

10.    Boditech
10.1    i–chroma DUO Analyzer

11.    Lifesign
11.1    DXpress Reader Analyzer

12.    LSI Medience Corporation
12.1    PATHFAST Analyzer

13.    Trinity Biotech
13.1    Meritas POC Analyzer

13.2    Trinity Biotech Point of Care Diagnostics Sales (2011 – 2022) 

14.    CardioGenics Holdings Inc.
14.1    QL Care Analyzer

15.    Mergers, Acquisitions and Licensing Agreements
15.1    Alere Inc

15.2    Response Biomedical

15.3    Abbott Laboratories

15.4    Siemens Healthineers

15.5    LSI Medience Corporation

15.6    Trinity Biotech

15.7    CardioGenics

16.    Emerging Markers

17.    Response Biomedical – Business & Marketing Strategy
17.1    Reducing Research & Development (R&D) and Sales & Marketing Expenses under the Cost Reduction Strategy

17.2    New Distributors in China

17.3    Strategic Alliances with Alere Medical in Japan

17.4    Response Biomedical Receives Health Canada Approval and CE Mark

18.    Roche – Business & Marketing Strategy
18.1    Implementing the Fully Connected Core Laboratory

18.2    Expansion of Rich Test Menu

18.3    Broadening the Diagnostics Portfolio

18.4    Patient Safety Comes First

19.    Siemens Healthineers – Business and Marketing Strategy
19.1    Siemens Healthineers Announces New Strategic Relationship

19.2    Cloud-Based Network Teamplay from Siemens Healthineers

19.3    Strategic Partnership between Siemens and Imricor

19.4    Siemens Healthineers Offers True High-Sensitivity Troponin I IVD Assay

19.5    Siemens Healthineers & Digitalization

19.6    Partnership between Siemens Healthineers and Ebit

20.    Boditech Med Inc – Business and Marketing Strategy
20.1    Boditech Med Acquires Immunostics

20.2    Strong Focus on Manpower and Investments in Research & Development Area

20.3    Advanced Technology in the Diagnostics Market

20.4    Marketing Channel
 

List of Figures

Figure 4 1: Worldwide – Alere Cardiology Net Sales (Million US$), 2011 – 2016
Figure 4 2: Worldwide – Forecast for Alere Cardiology Net Sales (Million US$), 2017 – 2022

Figure 5 1: Worldwide – Response Biomedical Cardiovascular Product Sales (Million US$), 2011 – 2016
Figure 5 2: Worldwide – Forecast for Response Biomedical Cardiovascular Product Sales (Million US$), 2017– 2022

Figure 6 1: Worldwide – Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 – 2016
Figure 6 2: Worldwide – Forecast for Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2017 – 2022

Figure 7 1: WIFI Set-up
Figure 7 2: QR CODE VIA BARCODE SCANNER Set-up
Figure 7 3: QR CODE VIA SMART PHONE APP Set-up
Figure 7 4: Connectivity of cobas h 232 in pre-hospital care and within hospital Set-up

Figure 13 1: Worldwide – Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2011 – 2016
Figure 13 2: Worldwide – Forecast for Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2017 – 2022

Figure 20 1: Boditech – R&D Manpower, Jan 2016
Figure 20 2: Boditech – R&D Investments (Million US$), Jan 2016
    

List of Tables    

Table 2 1: Cardiac Marker Companies – Comparative Tests Analysis
Table 2 2: Cardiac Marker Companies – Comparative Tests Analysis
Table 2 3: Cardiac Marker Companies – Comparative Tests Analysis

Table 3 1: Cardiac Marker Analyzer – Competitive Product Analysis
Table 3 2: Cardiac Marker Analyzer – Competitive Product Analysis

Table 6 1: i-STAT 1 Analyzer Specification

Table 12 1: PATHFAST – Technical Specifications

Table 15 1: Mergers, Acquisitions and Licensing Agreements, 2003 - 2017

Table 18 1: Roche - Centralised and Point of Care Solutions Product Launches, 2017
Table 18 2: Roche - Molecular Diagnostics Product Launches, 2017
Table 18 3: Roche - Tissue Diagnostics Product Launches, 2017
Table 18 4: Roche - Sequencing Product Launches, 2017